491 related articles for article (PubMed ID: 26208694)
1. Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis.
Li D; Kirsop J; Tang WH
Curr Diab Rep; 2015 Sep; 15(9):63. PubMed ID: 26208694
[TBL] [Abstract][Full Text] [Related]
2. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer.
Oellgaard J; Winther SA; Hansen TS; Rossing P; von Scholten BJ
Curr Pharm Des; 2017; 23(25):3699-3712. PubMed ID: 28641532
[TBL] [Abstract][Full Text] [Related]
3. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.
Gupta N; Buffa JA; Roberts AB; Sangwan N; Skye SM; Li L; Ho KJ; Varga J; DiDonato JA; Tang WHW; Hazen SL
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1239-1255. PubMed ID: 32212854
[TBL] [Abstract][Full Text] [Related]
4. The contributory role of gut microbiota in cardiovascular disease.
Tang WH; Hazen SL
J Clin Invest; 2014 Oct; 124(10):4204-11. PubMed ID: 25271725
[TBL] [Abstract][Full Text] [Related]
5. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
Romano KA; Vivas EI; Amador-Noguez D; Rey FE
mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
[TBL] [Abstract][Full Text] [Related]
6. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota metabolism of L-carnitine and cardiovascular risk.
Ussher JR; Lopaschuk GD; Arduini A
Atherosclerosis; 2013 Dec; 231(2):456-61. PubMed ID: 24267266
[TBL] [Abstract][Full Text] [Related]
8. Trimethylamine/Trimethylamine-N-Oxide as a Key Between Diet and Cardiovascular Diseases.
He S; Jiang H; Zhuo C; Jiang W
Cardiovasc Toxicol; 2021 Aug; 21(8):593-604. PubMed ID: 34003426
[TBL] [Abstract][Full Text] [Related]
9. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.
Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M
Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199
[TBL] [Abstract][Full Text] [Related]
10. The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of TMA production from choline, L-carnitine and related precursors by the human gut microbiota.
Day-Walsh P; Shehata E; Saha S; Savva GM; Nemeckova B; Speranza J; Kellingray L; Narbad A; Kroon PA
Eur J Nutr; 2021 Oct; 60(7):3987-3999. PubMed ID: 33934200
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.
Heianza Y; Ma W; Manson JE; Rexrode KM; Qi L
J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28663251
[TBL] [Abstract][Full Text] [Related]
12. Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?
Coutinho-Wolino KS; de F Cardozo LFM; de Oliveira Leal V; Mafra D; Stockler-Pinto MB
Eur J Nutr; 2021 Oct; 60(7):3567-3584. PubMed ID: 33533968
[TBL] [Abstract][Full Text] [Related]
13. Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk.
Anwar S; Bhandari U; Panda BP; Dubey K; Khan W; Ahmad S
J Pharm Biomed Anal; 2018 Sep; 159():100-112. PubMed ID: 29980011
[TBL] [Abstract][Full Text] [Related]
14. Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
Nowiński A; Ufnal M
Nutrition; 2018 Feb; 46():7-12. PubMed ID: 29290360
[TBL] [Abstract][Full Text] [Related]
15. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.
Koeth RA; Lam-Galvez BR; Kirsop J; Wang Z; Levison BS; Gu X; Copeland MF; Bartlett D; Cody DB; Dai HJ; Culley MK; Li XS; Fu X; Wu Y; Li L; DiDonato JA; Tang WHW; Garcia-Garcia JC; Hazen SL
J Clin Invest; 2019 Jan; 129(1):373-387. PubMed ID: 30530985
[TBL] [Abstract][Full Text] [Related]
16. Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
Eyupoglu ND; Caliskan Guzelce E; Acikgoz A; Uyanik E; Bjørndal B; Berge RK; Svardal A; Yildiz BO
Clin Endocrinol (Oxf); 2019 Dec; 91(6):810-815. PubMed ID: 31556132
[TBL] [Abstract][Full Text] [Related]
17. Trimethylamine
Canyelles M; Tondo M; Cedó L; Farràs M; Escolà-Gil JC; Blanco-Vaca F
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347638
[TBL] [Abstract][Full Text] [Related]
18. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial.
Cho CE; Taesuwan S; Malysheva OV; Bender E; Tulchinsky NF; Yan J; Sutter JL; Caudill MA
Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27377678
[TBL] [Abstract][Full Text] [Related]
19. Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota.
Hoyles L; Jiménez-Pranteda ML; Chilloux J; Brial F; Myridakis A; Aranias T; Magnan C; Gibson GR; Sanderson JD; Nicholson JK; Gauguier D; McCartney AL; Dumas ME
Microbiome; 2018 Apr; 6(1):73. PubMed ID: 29678198
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Microbiome in Heart Failure.
Kitai T; Kirsop J; Tang WH
Curr Heart Fail Rep; 2016 Apr; 13(2):103-9. PubMed ID: 26886380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
